Outcomes of Robotic Total Hip Arthroplasty
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Arthritis, Osteoarthritis (OA) |
| Therapuetic Areas: | Rheumatology |
| Healthy: | No |
| Age Range: | 20 - 75 |
| Updated: | 11/23/2013 |
| Start Date: | January 2013 |
| End Date: | January 2023 |
| Contact: | Charles Bragdon, PhD |
| Email: | cbragdon@partners.org |
| Phone: | 617-724-7544 |
Outcomes of Robotic Total Hip Arthroplasty: A Prospective Study
The objectives of this study are to evaluate the clinical value of robotic-assisted total
hip arthroplasty with respect to acetabular cup implantation, and to document the long-term
clinical outcome of patients with Total Hip Arthroplasty (THA). IRB approval will be
obtained at every study site to evaluate the basic clinical outcomes and post-operative
component placement accuracy of each MAKO® THA patient.
The hypothesis is that robotic preparation of the acetabulum will significantly reduce the
variability and inaccuracy in the component alignment parameters that lead to post-operative
complications, including implant failure.
Inclusion Criteria:
- Male or female
- 20 to 75 years of age
- Subjects requiring primary total hip replacement
- Contralateral hip should be relatively free from arthritis for comparison purposes,
specifically with less than a grade of 2 on the Kellgren-Lawrence Scale.
- Subjects diagnosed with osteoarthritis or traumatic arthritis
- Subjects with avascular necrosis
- Subjects who demonstrate the ability to return for follow-up for the next 10 years
Exclusion Criteria:
- Subjects with difficulty understanding protocol for any reason
- Subjects with a limited life span
- Subjects with inflammatory hip disease, previous joint infection, or those requiring
hip revision surgery
- Female subjects who are pregnant, or who plan to get pregnant while enrolled in the
study
We found this trial at
1
site
Click here to add this to my saved trials
